PetVivo Holdings, Inc.

PetVivo Holdings, Inc. is a U.S.-based animal health company focused on veterinary medical devices and therapeutics. Its core commercial product is Spryng®, which is sold to veterinarians and distributed through animal-health wholesalers and distribution partners.

−749,1 %

66,1 %

−917,4 %

+0,8 %

1.35

0.96

— PetVivo Holdings, Inc.
%
Spryng® product sales100% Sales of the company's lead veterinary medical device used in animal care settings.
Direct veterinary sales0% Sales made directly to veterinarians through the company's own sales efforts.
Distributor sales0% Sales routed through animal-health distribution partners such as MWI, Covetrus, Vedco, and Clipper.

PetVivo sells primarily into the veterinary market, where veterinarians buy Spryng® for use in animal treatment...

  • Veterinariansprimary

    Buy Spryng® directly for use in treating animal patients and for clinic inventory.

  • Animal-health distributorsprimary

    Purchase and resell Spryng® to veterinary customers through established distribution networks.

  • Veterinary clinics and practicessecondary

    Use or stock the product as part of routine animal care and treatment workflows.

  • Pet ownersemerging

    Influence demand indirectly through willingness to pursue veterinarian-recommended treatments.

PetVivo is headquartered in the United States and its commercial activity is centered on the U.S. veterinary market...

  • Headquartered in the United States
  • Primary commercial market is U.S. veterinarians
  • Sales are supported by U.S. distribution partners
  • No country-level revenue disclosure in the excerpts

PetVivo’s strategy is to expand commercialization of Spryng® through a mix of direct sales and third-party distribution...

01
Expand U.S. commercialization of Spryng®short-term

Revenue growth depends on broader veterinarian adoption and stronger channel execution.

02
Strengthen distribution relationshipsshort-term

Third-party distributors extend market reach and are important to product placement.

03
Improve marketing and product promotionmedium-term

Awareness and promotion are necessary to drive veterinarian demand in a competitive market.

PetVivo faces execution risk because its business depends on building a sales force, managing distributors, and...

critical

Going-concern and financing risk

The company has disclosed substantial doubt about its ability to continue as a going concern, making access to capital critical.

Scope
Equity financing and operating runway
Materiality
high
high

Dependence on Spryng® commercialization

The company’s revenue base is concentrated in a single lead product, so weak adoption would directly limit growth.

Scope
Spryng®
Materiality
high
high

Loss or disruption of distribution agreements

A large share of revenue is generated through distributors, so partner changes can quickly affect sales reach.

Scope
MWI, Covetrus, Vedco, Clipper
Materiality
high
high

Nasdaq delisting / OTCQB trading status

Loss of a senior exchange listing can reduce liquidity, investor access, and financing flexibility.

Scope
Public market access
Materiality
high
medium

Competition from larger animal-health companies

Competitors have greater financial, technical, and commercial resources and established brands.

Scope
Veterinary therapeutics and devices
Materiality
high
Going-concern assessment
Affects audit opinion, disclosure, and valuation assumptions
Stock-based compensation
Impacts operating expenses and share count
Warrants and preferred stock conversions
Affects equity, dilution, and potentially fair value measurements
Non-cash consulting consideration
Affects SG&A and equity balances

: 29/04/2026